We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$14.3B
AUM Growth
+$668M
Cap. Flow
+$57.6M
Cap. Flow %
0.4%
Top 10 Hldgs %
33.85%
Holding
992
New
136
Increased
359
Reduced
297
Closed
166

Top Buys

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$83.9M
2
BNS icon
Scotiabank
BNS
+$80.5M
3
WPM icon
Wheaton Precious Metals
WPM
+$62.4M
4
NGD
New Gold Inc
NGD
+$61.4M
5
CVE icon
Cenovus Energy
CVE
+$55.2M

Top Sells

Rank Stock Value
1
SU icon
Suncor Energy
SU
+$112M
2
CNQ icon
Canadian Natural Resources
CNQ
+$70M
3
GG
Goldcorp Inc
GG
+$42.7M
4
MFC icon
Manulife Financial
MFC
+$41.2M
5
TRI icon
Thomson Reuters
TRI
+$39.7M

Sector Composition

Rank Sector Weight
1 Financials 29.84%
2 Materials 13.95%
3 Energy 13.19%
4 Technology 9.92%
5 Industrials 9.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSIT icon
801
GSI Technology
GSIT
$255M
$48K ﹤0.01%
10,175
– –
CMLS
802
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$46K ﹤0.01%
17,384
– –
CALA
803
DELISTED
Calithera Biosciences, Inc
CALA
$46K ﹤0.01%
710
+185
+35% +$11.9K
OPCH icon
804
Option Care Health
OPCH
$3.57B
$44K ﹤0.01%
3,800
-14,975
-80% -$162K
STCN
805
DELISTED
Steel Connect, Inc. Common Stock
STCN
$43K ﹤0.01%
2,778
– –
ANTH
806
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$43K ﹤0.01%
1,713
-5,508
-76% -$139K
TTPH
807
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$42K ﹤0.01%
550
-325
-37% -$26K
VXRT
808
DELISTED
Vaxart
VXRT
$40K ﹤0.01%
1,889
-45
-2% -$712
NNA
809
DELISTED
Navios Maritime Acquisition Corporation
NNA
$40K ﹤0.01%
1,960
+280
+17% +$6.19K
MCHX icon
810
Marchex
MCHX
$77.5M
$38K ﹤0.01%
13,825
+1,900
+16% +$5.63K
TGB
811
Trekor Metals
TGB
$3.2B
$37K ﹤0.01%
77,800
-131,700
-63% -$68.5K
FRTX
812
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$36K ﹤0.01%
38
– –
RBCN
813
DELISTED
Rubicon Technology, Inc.
RBCN
$35K ﹤0.01%
5,575
– –
GLF
814
DELISTED
GulfMark Offshore, Inc. Common Stock
GLF
$34K ﹤0.01%
20,000
-37,300
-65% -$97.5K
FLNA
815
Filana Therapeutics
FLNA
$45.1M
$31K ﹤0.01%
4,486
-314
-7% -$5.2K
APVO icon
816
Aptevo Therapeutics
APVO
$5.31M
– –
0
– –
PLX icon
817
Protalix BioTherapeutics
PLX
$211M
$29K ﹤0.01%
5,070
– –
BEBE
818
DELISTED
Bebe Stores Inc
BEBE
$29K ﹤0.01%
4,120
– –
SRRA
819
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$27K ﹤0.01%
370
+95
+35% +$7.34K
CETV
820
DELISTED
Central European Media Enterprises Ltd
CETV
$25K ﹤0.01%
10,825
-6,800
-39% -$15.6K
CBK
821
DELISTED
Christopher & Banks Corporation
CBK
$24K ﹤0.01%
+16,500
New +$29.8K
UTI icon
822
Universal Technical Institute
UTI
$1.41B
$18K ﹤0.01%
+10,000
New +$23.3K
AVEO
823
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$16K ﹤0.01%
1,850
– –
VERU icon
824
Veru
VERU
$46.7M
$15K ﹤0.01%
+1,270
New +$16.5K
PCO
825
DELISTED
Pendrell Corporation - Class A
PCO
$7K ﹤0.01%
+10
New +$6.6K
31 32
33
34 35

Similar funds

State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
PEAK6
PEAK6 Chicago, Illinois $42.6B AUM 66.24% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2016 Portfolio in Review

As of Q3 2016, Connor, Clark & Lunn Investment Management (CC&L) held 992 positions worth $14.3B, up 4.9% from $13.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q3 2016 filing shows 136 new, 359 increased, 297 reduced and 166 closed positions. Its largest new stake was RSP Permian, Inc.: 812,500 shares worth $31.5M. The largest sale was Suncor Energy, an estimated $112M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Materials and Energy.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q3 2016 buy was RSP Permian, Inc.: 812,500 shares worth $31.5M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Enbridge in Q3 2016, an estimated $83.9M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q3 2016 reduction was Suncor Energy, cutting an estimated $112M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Hudbay in Q3 2016, selling an estimated $24.4M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 34% of its $14.3B portfolio in Q3 2016.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 136 new positions and closed 166 in Q3 2016.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 4.9% quarter-over-quarter to $14.3B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2016, filed 15 Nov 2016.